This case report describes an outer retinal abnormality associated with taking a RET inhibitor during a clinical trial in a 52-year-old patient with right lung adenocarcinoma and a RET gene fusion.
Visionary News & Insightful Strategy
Footer
A RETINA-SPECIFIC ORGANIZATION
It’s clearly an advantage to work with a consulting group that’s focused on your industry. The team at Retina Consultant has over 50 years of retina-specific experience in healthcare business, practice management, marketing & operations.
We’ve got our eyes on working with the best retina groups and vendors in the industry.
See the best; get in touch.
Recent
- VLOG: NeuroOp Guru: Can AI distinguish between papilledema and optic disc drusen using color fundus photos?
- VIDEO: Expert shares thoughts on gel stent implantation
- New research links retinal imaging and deep learning to improved schizophrenia detection
- Eyebright Medical receives Class III Certificate from National Medical Products Administration in China for its phakic intraocular lens
- FDA accepts revised supplemental New Drug Application for IZERVAY
Leave a Reply